Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422848-25-000069
Filing Date
2025-05-13
Accepted
2025-05-13 11:32:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5686
  Complete submission text file 0001422848-25-000069.txt   7364
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-56595 | Film No.: 25938172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A